4 years ago

Commentary on the recent international multicentre study (EUVAS) on antineutrophil cytoplasmic antibodies

Antineutrophil cytoplasmic antibodies (ANCAs)-associated vasculitis (AAV) is a group of potentially life-threatening conditions that require early and accurate diagnosis, most often based on a combination of clinical and serological features.1 Most of the therapeutic modalities have immune-suppressing activity and can result in serious consequences, especially if applied to patients without AAV, such as those with infectious diseases, which may have clinical features that mimic AAV. Because an early and accurate diagnosis of AAV is a clinical imperative, both the differential diagnosis and the working diagnosis leading to urgent initial treatment are critical steps in the clinical care pathway. Even then, refinement of the diagnosis might be required during the clinical course after the initial choice of therapeutic strategies.

In this context and with interest we read the recent article by Damoiseaux et al2 summarising the results from a large international multicentre study on ANCA. The...

Publisher URL: http://ard.bmj.com/cgi/content/short/76/10/e38

DOI: 10.1136/annrheumdis-2017-211157

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.